Taipa, Macao

Beixian Zhou

This inventor holds 1 USPTO granted patent. Top assignee: Macau University of Science and Technology. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Beixian Zhou: Innovator in Influenza Treatment

Introduction

Beixian Zhou is a notable inventor based in Taipa, Macau. He has made significant contributions to the field of medicine, particularly in the treatment of viral diseases such as influenza. His innovative work has led to the development of a unique compound aimed at combating this widespread illness.

Latest Patents

Zhou holds a patent for "Compounds and methods for treating influenza." This patent describes a compound that includes a specific structure of Formula (I) and outlines a preparation method. The compound features various functional groups, including hydroxyl, aldehyde, or acyl groups, and is designed to be administered to subjects suffering from viral diseases. The method involves providing an effective amount of the compound or its solvate to the affected individual.

Career Highlights

Beixian Zhou is affiliated with the Macau University of Science and Technology, where he conducts research and develops innovative solutions in the field of medicine. His work has garnered attention for its potential impact on public health, particularly in the context of influenza treatment.

Collaborations

Zhou collaborates with esteemed colleagues such as Jingrong Wang and Qitong Feng. Their combined expertise contributes to the advancement of research and development in their respective fields.

Conclusion

Beixian Zhou's contributions to the treatment of influenza through his patented compounds highlight his role as an innovator in the medical field. His work not only showcases his dedication to improving health outcomes but also emphasizes the importance of collaboration in scientific research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…